Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease
- 13 October 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (15) , 1487-1494
- https://doi.org/10.1161/01.cir.98.15.1487
Abstract
Background—The association between oxidative modifications of LDL and coronary artery disease (CAD) is suspected but not established. Therefore, the association between plasma levels of oxidized LD...Keywords
This publication has 29 references indexed in Scilit:
- Secretory group II phospholipase A2 in human atherosclerotic plaquesAtherosclerosis, 1995
- Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.Journal of Clinical Investigation, 1995
- Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitroAtherosclerosis, 1995
- Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.Journal of Clinical Investigation, 1995
- Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.Journal of Clinical Investigation, 1995
- Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate. A possible role for phosphatidic acid.Journal of Clinical Investigation, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro.The Journal of cell biology, 1993
- Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in AtherosclerosisAnnual Review of Biochemistry, 1983